PathAI is a leading provider of integrated AI and digital pathology solutions; dedicated to enhancing workflow and operational efficiency in pathology labs worldwide. Founded in 2016 and based in Boston; Massachusetts; PathAI leverages advanced machine learning and computer vision to improve diagnostic accuracy and support personalized medicine.

PathAI's platform offers a range of services including biopharmacy lab services; clinical development services; drug and diagnostic development; and more. The company's AISight^® digital pathology image management system integrates AI algorithms to enhance pathology workflows; particularly in oncology. This system supports various scanners and integrates seamlessly with major laboratory information systems (LIS); providing an intuitive user experience for pathologists.

In February 2025; PathAI announced a strategic partnership with Rede D'Or; Brazil's largest integrated healthcare network; to implement their AISight^® image management system across 78 hospitals. This marks PathAI's entry into the South American market and demonstrates the growing adoption of AI-powered pathology solutions globally[1][3].

PathAI has also developed PathAssist Derm; a tool designed to assist dermatopathologists in diagnosing skin malignancies. The tool can predict diagnoses for 17 skin malignancies and has shown strong diagnostic accuracy across a wide range of conditions[5][7]. While currently for research use only; PathAI is working towards FDA clearance for clinical use[5].

Looking ahead; PathAI envisions a future where AI plays a critical role in dermatologic care; potentially enabling patients to monitor skin changes at home with AI-powered alerts for professional evaluation[7]. The company continues to focus on expanding its BioPharma services; enhancing AP Laboratory solutions; and entering new markets.

PathAI is best suited for biopharmaceutical companies; researchers; and pathology laboratories seeking to enhance diagnostic precision and operational efficiency. The company's commitment to innovation and strategic partnerships positions it as a leader in the rapidly evolving field of AI-powered pathology.

For pricing and specific deployment details; interested parties should contact PathAI directly as this information is not publicly disclosed.

Product Categories

• Artificial Intelligence
• Digital Pathology
• Healthcare Technology
• Oncology Diagnostics

Product Features

• AI-Powered Pathology Tools
• Digital Pathology Image Management
• Biopharmacy Lab Services
• Clinical Development Services
• Drug and Diagnostic Development
• Dermatopathology Diagnostics

Available Deployment Type(s)

• Cloud-Based
• On-Premise Integration

Available Pricing Model(s)

• Custom Pricing
• Subscription-Based